European Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

European Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
    Update Available - Forecast 2024-2030   

Published: Feb 2020 | Report Code: OMR2021181 | Category : Biotechnology | Delivery Format: /

European digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 7.6% during the forecast period. Europe is considered as one of the major regions in the global dPCR and qPCR market. The market in Europe is driven by an increasing prevalence of chronic diseases such as cancer and CVDs. Government initiatives, programs and funding for cancer-related programs are also contributing to the rise in research activities for such chronic diseases, which in turn, is offering growth to the global dPCR and qPCR market in the region. In Europe, several key players are present which are contributing to the growth of the global dPCR and qPCR markets. This includes BioMérieux S.A., F. Hoffmann-La Roche AG, and QIAGEN N.V.

In Europe, thermophilic Campylobacter is one of the major bacterial food pathogens. Hygienic measures in the whole food chain, starting at primary production, are considered as the most effective tool to fight campylobacteriosis. Risk assessment is based on Campylobacter quantification by conventional microbiology. This methodology, however, is prone to underestimation of the infectious bacterial contamination as “viable, however, non-cultivable” Campylobacter is not detected. This problem affects several other foodborne pathogens. The application of dPCR may provide a step towards quantification in this important field.

Realizing the importance of dPCR and qPCR, the market players are regularly working in this field and updating their existing technologies. For instance, in January 2019, QIAGEN N.V. acquired FORMULATRIX digital PCR technology. QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s focus in assay development and automation. 

Research Methodology

The market study of the European dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  1. European dPCR and qPCR Market Research and Analysis, By Technology
  2. European dPCR and qPCR Market Research and Analysis, By Product
  3. European dPCR and qPCR Market Research and Analysis, By Application

The Report covers:

  • Comprehensive research methodology of the European dPCR and qPCR market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the European DPCR and qPCR market.
  • Insights about market determinants which are stimulating the European dPCR and qPCR market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Country

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. European dPCR and qPCR Market by Technology 

5.1.1. Quantitative PCR (qPCR)

5.1.2. Digital PCR (dPCR)

5.2. European dPCR and qPCR Market by Product

5.2.1. Reagents and Consumables

5.2.2. Instruments

5.2.3. Software

5.3. European dPCR and qPCR Market by Application

5.3.1. Research Application

5.3.2. Clinical Application

5.3.3. Forensic Application

6. Regional Analysis

6.1. UK

6.2. Germany

6.3. Italy

6.4. Spain

6.5. France

6.6. Rest of Europe

7. Company Profiles

7.1. Analytik Jena AG 

7.2. BioMérieux S.A.

7.3. Bio-Rad Laboratories, Inc.

7.4. Danaher Corp.

7.5. Eppendorf AG

7.6. F. Hoffmann-La Roche AG

7.7. Merck KGaA

7.8. Qiagen N.V.

7.9. Siemens AG

7.10. Thermo Fisher Scientific Inc.

1. EUROPEAN DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

2. EUROPEAN DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION) 

3. EUROPEAN DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION) 

4. EUROPEAN DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION) 

1. EUROPEAN DPCR AND QPCR MARKET SHARE BY COUNTRY, 2018 VS 2025 (%)

2. EUROPEAN DPCR AND QPCR MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)

3. EUROPEAN DPCR AND QPCR MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)

4. EUROPEAN DPCR AND QPCR MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

5. UK DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)

6. GERMANY DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)

7. ITALY DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)

8. SPAIN DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)

9. FRANCE DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)

10. REST OF EUROPE DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)